Resilience of melanoma diagnostics at a tertiary-care hospital during the SARS-CoV-2 pandemic.

Jobbagy, Soma; Chaudet, Kristine M; Gayhart, Matthew; Klepeis, Veronica E; Boland, Genevieve; Tsao, Hensin; Duncan, Lyn M

Jobbagy, Soma; Chaudet, Kristine M; Gayhart, Matthew; Klepeis, Veronica E; Boland, Genevieve; Tsao, Hensin; Duncan, Lyn M.

Afiliação

Jobbagy S; Pathology Service, Massachusetts General Hospital, Boston, Massachusetts.
Chaudet KM; Harvard Medical School, Boston, Massachusetts.
Gayhart M; Pathology Service, Massachusetts General Hospital, Boston, Massachusetts.
Klepeis VE; Harvard Medical School, Boston, Massachusetts.
Boland G; Pathology Service, Massachusetts General Hospital, Boston, Massachusetts.
Tsao H; Harvard Medical School, Boston, Massachusetts.
Duncan LM; Pathology Service, Massachusetts General Hospital, Boston, Massachusetts.

JAAD Int ; 9: 78-79, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36061239

Palavras-chave

Breslow; COVID-19; SARS-CoV-2; melanoma; pandemic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: JAAD Int Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google